Intratumoral administration of plant virus nanoparticles, cowpea mosaic virus (CPMV), for in situ vaccination (ISV) is an effective cancer immunotherapy. CPMV ISV induces a durable, targeted, systemic anti-tumor immune response, which can be further enhanced with OX40 agonistic antibody (aOX40), a T cell co-stimulator. While CPMV is noninfectious to mammals, it is hazardous to some plants and could present environmental concerns.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile